AUA 2021
AUA 2021
American Urological Association 2021 Annual Meeting
Advertisement
GU Oncology Now EditorsAUA 2021 | May 5, 2023
Investigators relied on medical claims data for adults with urinary stone disease who filled a prescription for the agents.
Read More
GU Oncology Now EditorsAUA 2021 | May 5, 2023
In the United States, urinary incontinence represents a significant cause of morbidity among women.
GU Oncology Now EditorsAUA 2021 | September 13, 2021
There is little to no clinical value in surveillance of pulmonary recurrence following resection of T1a renal cell carcinoma.
GU Oncology Now EditorsAUA 2021 | September 13, 2021
Nadofaragene firadenovec has shown promising results for bladder cancer.
Robert DillardAUA 2021 | May 5, 2023
The investigators collected data on participant demographics, diet, as well as degree of erectile dysfunction.
Robert DillardAUA 2021 | May 5, 2023
The 12-month analysis of the ILLUMINATE-A trial included patients aged 6 years and older with primary hyperoxaluria type 1.
Robert DillardAUA 2021 | May 5, 2023
DA8010, an investigational muscarinic M3 receptor antagonist, led to significant changes in 24-hour urinary frequency.
Robert DillardAUA 2021 | May 5, 2023
However, clinicians should take operative time of mini percutaneous nephrolithotomy (MPNL) into consideration.
Robert DillardAUA 2021 | May 5, 2023
In recent years, researchers have investigated the effects of these interventions on various aspects of physical health.
Robert DillardAUA 2021 | September 10, 2021
Whether plant-based diets played a role in prostate cancer risk had yet to be fully determined.
Robert DillardAUA 2021 | September 10, 2021
Increased DNA damage, ER stress response induction, and inflammatory signaling was observed in smokers.
Robert DillardAUA 2021 | September 10, 2021
Patients with COVID-19 reported increased genitourinary symptoms.
Advertisement
Advertisement
Advertisement